A case of membranous proliferative glomerulonephritis-type IgA nephropathy modified by nintedanib

Key Points

• Nintedanib treatment improved renal function in the patient with IgA nephropathy, indicating therapeutic effects.
• The case highlights how nintedanib may alter key glomerular parameters, contributing to improved health.
• Observational case analysis assessed the impact of nintedanib on membranous proliferative glomerulonephritis.
• This finding supports further investigation into nintedanib's role in treating similar kidney conditions.